Guardant Health Shares Move Lower On $350M Public Offering: The Details

Guardant Health Inc GH shares are trading lower Tuesday after the company announced an offering

What Happened: Guardant Health commenced an underwritten public offering of 12.5 million shares of its common stock at $28 per share. The company also granted the underwriters a 30-day option to purchase up to an additional 1.875 million shares. 

The offering is expected to close on or about May 25. Guardant Health anticipates $350 million in gross proceeds. 

Guardant Health is a precision oncology company focused on fighting cancer through proprietary tests, data sets and analytics. 

See Also: US Stocks Poised For Flat Open On Debt Ceiling Impasse: Why This Analyst Thinks October Lows 'Won't Be Violated'

GH Price Action: Guardant Health has a 52-week high of $62.55 and a 52-week low of $20.67. 

The stock was down 3.57% at $29.70 at the time of writing, per Benzinga Pro.

Photo: Tatiana from Pixabay.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsMoverswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!